Alto Neuroscience (ANRO) Interest Expenses (2023 - 2026)

Alto Neuroscience has reported Interest Expenses for 4 years, with the latest figure at $545000.0 in Q1 2026.

• Quarterly Interest Expenses fell 72.75% year-over-year to $545000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $653000.0 (down 67.35% YoY) and the FY2025 annual result came in at $52.1 million, up 39.42% from the prior year.
• Interest Expenses climbed to $545000.0 in Q1 2026 per ANRO's latest filing, from -$240000.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $1.8 billion in Q3 2025 and troughed at -$240000.0 in Q4 2025.
• A 4-year average of $169.7 million and a median of $400000.0 in 2023 frame the typical range for Interest Expenses.
• The widest YoY moves for Interest Expenses: up 527120.63% in 2025, down 23900.0% in 2025.
• Over 4 years, Interest Expenses stood at -$102000.0 in 2023, then jumped by 99.02% to -$1000.0 in 2024, then tumbled by 23900.0% to -$240000.0 in 2025, then soared by 327.08% to $545000.0 in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $545000.0, -$240000.0, and $1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.